Solventum Corporation (SOLV)

Market Cap	12.65B
Revenue (ttm)	8.39B
Net Income (ttm)	380.00M
Shares Out	173.01M
EPS (ttm)	2.18
PE Ratio	33.48
Forward PE	12.44
Dividend	n/a
Ex-Dividend Date	n/a

Volume	410,859
Open	74.38
Previous Close	71.95
Day's Range	72.98 - 74.98
52-Week Range	55.62 - 85.92
Beta	n/a
Analysts	Hold
Price Target	84.57 (+15.64%)
Earnings Date	Aug 7, 2025

About ACCD

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2023
• Employees: 22,000
• Stock Exchange: NYSE
• Ticker Symbol: SOLV
• Website: https://www.solventum.com

Financial Performance

In 2024, Solventum's revenue was $8.25 billion, an increase of 0.70% compared to the previous year's $8.20 billion. Earnings were $479.00 million, a decrease of -64.41%.

Analyst Summary

According to 11 analysts, the average rating for SOLV stock is "Hold." The 12-month stock price target is $84.57, which is an increase of 15.64% from the latest price.

Price Target

$84.57

(15.64% upside)

Analyst Consensus: Hold